Relationship between Clinicopathological Features and Expression of COX-2 among Colorectal Cancer Patients: A Prospective Observational Study

Authors

  • Mohamad Romdhoni Department of Surgery, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
  • Kiki Lukman Department of Surgery, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
  • Reno Rudiman Department of Surgery, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
  • Andriana Purnama Department of Surgery, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Bambang Am'am Setya Sulthana Degrees Department of Surgery, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Tommy Ruchimat Department of Surgery, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Alma Wijaya Department of Surgery, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Yunia Sribudiani Degrees Department of Surgery, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
  • Prapanca Nugraha Department of Surgery, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia

DOI:

https://doi.org/10.30829/contagion.v7i3.24233

Abstract

Colorectal cancer (CRC) is the third most common cancer globally and a leading cause of cancer-related mortality. Cyclooxygenase-2 (COX-2) plays a critical role in CRC pathogenesis by promoting inflammation, tumor proliferation, and metastasis. COX-2 inhibitors, such as NSAIDs, have shown potential in reducing CRC progression. However, the relationship between COX-2 expression and clinicopathological features remains controversial. This study aims to assess the correlation between COX-2 expression and clinicopathological characteristics in CRC patients in Indonesia. A prospective observational study was conducted on 81 CRC patients at a tertiary hospital in West Java, Indonesia, from January to June 2024. COX-2 expression was quantified using qPCR from tumor tissue samples. Clinicopathological data, including age, sex, tumor grade, stage, and complications, were collected and analyzed. Among the 81 participants, 81.5% were over 50 years old. Low-grade adenocarcinoma was the most prevalent histopathological type (73%), followed by high-grade adenocarcinoma (11%) and mucinous adenocarcinoma (11%). The majority of cases were in regional or early stages (74%), while 26% were in late stages. Higher COX-2 expression was more frequent in males, rectal tumors, high- grade adenocarcinomas, advanced stages, and metastatic cases. Although no statistically significant association was found, a trend toward increased COX-2 expression in advanced CRC was observed. No significant association was found between COX-2 expression and clinicopathologic characteristics of CRC. However, higher COX-2 expression may be associated with advanced disease. Keyword: Clinicopathological features, Colorectal cancer, Cyclooxygenase-2, Inflammation, Metastasis

References

Cercek, A., Chatila, W. K., Yaeger, R., Walch, H., Dos, G., Fernandes, S., Krishnan, A., Palmaira, L., Maio, A., Srinivasan, P., Bandlamudi, C., Salo-mullen, E., Segal, N., Tejada, P. R., Belanfanti, K., Galle, J., Joseph, V., Varghese, A., Reidy-lagunes, D., … Stadler, Z. K. (2021). A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. Journal of the National Cancer Institute, 113(12), 1683-1692. https://doi.org/10.1093/jnci/djab124

Cuschieri, S. (2019). The STROBE guidelines. Saudi Journal of Anesthesia, 13(1), 31-34. https://doi.org/10.4103/sja.SJA

Durand-onaylı, V., Haslauer, T., Härzschel, A., & Hartmann, T. N. (2018). Rac GTPases in Hematological Malignancies. International Journal of Molecular Sciences, 19, 1-24. https://doi.org/10.3390/ijms19124041

Elm, E. Von, Altman, D. G., Peter, C. G., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2022). Improving Reporting of Observational Studies in Epidemiology (STROBE): Clarification and Refinement. Вопросы Современной Педиатрии, 21(3), 173-207. https://doi.org/10.17816/DD70821.

Georgiou, A., Khakoo, S., Edwards, P., Minchom, A., Kouvelakis, K., Kalaitzaki, E., Nobar, N., Calamai, V., Ifijen, M., Husson, O., Watkins, D., Rao, S., Chau, I., & Cunningham, D. (2019). Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center. Cancers, 11(10), 1-15.

Gök, M. A., Kafadar, M. T., & Yeğen, S. F. (2021). Perforated colorectal cancers : clinical outcomes of 18 patients who underwent emergency surgery. Gastroenterology Review, 16(2), 161-165. https://doi.org/https://doi.org/10.5114/pg.2021.106667

Goradel, N. H. (2018). Cyclooxygenase - 2 in cancer : A review. Journal of Cellular Physiology, 234(5), 1-17. https://doi.org/10.1002/jcp.27411

Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2011). Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer and Metastasis Reviews, 29(3), 405-434. https://doi.org/10.1007/s10555-010-9235-2.Regulation

Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024). Journal of the National Cancer Center Cancer incidence and mortality in China , 2022 ✩. Journal of the National Cancer Center, 4(January), 47-53. https://doi.org/10.1016/j.jncc.2024.01.006

He, K., Wang, Z., Luo, M., Li, B., Ding, N., Li, L., He, B., Wang, H., & Cao, J. (2023). Metastasis organotropism in colorectal cancer : advancing toward innovative therapies. Journal of Translational Medicine, 21(612), 1-23.

Hu, Y., Li, W., Cheng, X., Yang, H., She, Z., Cai, J., Li, H., & Zhang, X. (2024). Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases. Circulation Research, 135(1), 222-260. https://doi.org/10.1161/CIRCRESAHA.124.324383

Ibrahim, N. I., Shamsudin, S. H., Lee, S. K., Emilia, S., & Sharif, T. (2023). Human Pathology Reports Prognostic significance of Cyclooxygenase-2 expression in colorectal adenoma and Adenocarcinoma : A clinicopathologic study. Human Pathology Reports, 31(March), 1-9. https://doi.org/https://doi.org/10.1016/j.hpr.2023.300692

Indratama, I. M. B., Made, N., Anggreni, R., Ade, L., & Andriyani, G. (2024). Profile of Colorectal Cancer Patients Undergoing Chemotherapy at RSU Grha Bhakti Medika Klungkung in 2023-2024. Intisari Sains Medis, 15(3), 1100-1105. https://doi.org/10.15562/ism.v15i3.2152

Kasi, A., Handa, S., Bhatti, S., Umar, S., Bansal, A., & Sun, W. (2021). Molecular Pathogenesis and Classification of Colorectal Carcinoma. HHS Public Access, 16(5), 97-106. https://doi.org/10.1007/s11888-020-00458-z

Kolawole, O. R., & Kashfi, K. (2022). NSAIDs and Cancer Resolution : New Paradigms beyond Cyclooxygenase. International Journal of Molecular Sciences, 23(3), 1-32. https://doi.org/https://doi.org/10.3390/ijms23031432

Kulesza, A., Paczek, L., & Hoffman, F. (2023). The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells. Biomedicines, 11(2), 1-21. https://doi.org/10.3390/biomedicines11020445

Li, J., Ma, X., Chakravarti, D., Shalapour, S., & Depinho, R. A. (2021). Genetic and biological hallmarks of colorectal cancer. https://doi.org/10.1101/gad.348226.120.GENES

Low, E. E., Demb, J., Liu, L., & Earles, A. (2021). Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology, 159(2), 492-501. https://doi.org/10.1053/j.gastro.2020.01.004.Risk

Meester, R. G. S., Mannalithara, A., Lansdorp-Vogelaar, I., & Ladabaum, U. (2019). Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years , 1975-2015. Jama, 321(19). https://doi.org/10.1001/jama.2019.3076

Miller, K. D., Sauer, A. G., & Fedewa, S. A. (2020). Colorectal Cancer Statistics , 2020. American Cancer Society, 70(3), 145-164. https://doi.org/10.3322/caac.21601

Mizuno, R., Kawada, K., & Sakai, Y. (2019). Prostaglandin E2 / EP Signaling in the Tumor Microenvironment of Colorectal Cancer oxygen species. International Journal of Mo, 20(24).

Nasry, W. H. S., Rodriguez-lecompte, J. C., & Martin, C. K. (2018). Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. Cancers, 10(10), 1-21. https://doi.org/10.3390/cancers10100348

Negi, R. K. V. and D. S. (2020). The Development of COX-1 and COX-2 Inhibitors: A Review. International Journal of Pharmaceutical Sciences and Research, 11(8), 3544-3555. https://doi.org/10.13040/IJPSR.0975-8232.11(8).3544-55

Negi, R. R., Rana, S. V., Gupta, V., Gupta, R., Dani, V., Prasad, K. K., & Dhawan, D. K. (2019). Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients. Asian Pacific Journal of Cancer Prevention, 20(6), 1675-1681. https://doi.org/10.31557/APJCP.2019.20.6.1675

Nigam, M., Prakash, A., Kumar, V., Bandhu, D., Tiwari, V., Gabriela, S., Florina, A., & Radu, A. (2023). Biomedicine & Pharmacotherapy Evaluation of the association of chronic inflammation and cancer : Insights and implications. Biomedicine & Pharmacotherapy, 164(June), 1-27. https://doi.org/10.1016/j.biopha.2023.115015

Norel, X., Sugimoto, Y., Ozen, G., Abdelazeem, H., Amgoud, Y., Bouhadoun, A., Bassiouni, W., Goepp, M., & Mani, S. (2025). Differences and similarities between human and rodents concerning prostaglandin EP1-4 and IP receptors : Specific roles in pathophysiologic conditions International Union. International Union of Basic and Clinical Pharmacology, 910-968. https://doi.org/10.1124/pr.120.019331

Oi, I., Wong, L., Lam, Y. T., Lam, K. F., Cowling, B. J., & Leung, G. M. (2021). Demographic and Epidemiological Contributions to Recent Trends in Cancer Incidence in Hong Kong. Cancers, 13(22), 1-11.

Parmar, S., & Easwaran, H. (2022). Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterology Report, 10(March), 1-17. https://doi.org/10.1093/gastro/goac035

Perez, S., & Eisenstein, S. (2024). Cancer in Anal Fistulas. Clinics in Colon and Rectal Surgery, 37(1), 41-45. https://doi.org/10.1055/s-0043-1762928

Punganuru, S. R., Madala, H. R., & Mikelis, C. M. (2018). Conception , synthesis , and characterization of a rofecoxib- combretastatin hybrid drug with potent cyclooxygenase-2 ( COX-2 ) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models. Oncotarget, 9(40), 26109-26129.

Purnama, A., Lukman, K., Rudiman, R., Prasetyo, D., Fuadah, Y., Nugraha, P., & Siulinda, V. (2023). The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer : A systematic review and meta analysis. Heliyon, 9(September), 1-9.

Rashid, G., Khan, N. A., Elsori, D., Rehman, A., Tanzeelah, Ahmad, H., Maryam, H., Rais, A., Usmani, M. S., Babker, A. M., Kamal, M. A., & Hafez, W. (2023). drugs and biomarkers : A new paradigm in colorectal cancer. Pathology, 10(March), 1-21. https://doi.org/10.3389/fmed.2023.1130710

Rebuzzi, F., Ulivi, P., & Tedaldi, G. (2023). Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? International Journal of Molecular Sciences, 24(3), 1-23. https://doi.org/https://doi.org/10.3390/ijms24032137

Rudiman, R., Subspbd, K., Wijaya, A., Subspbd, K., Sribudiani, Y., Soedjana, H. S., Subspel, K., & Wiraswati, H. L. (2023). Identification of KRAS mutation and HER2 expression in Indonesian colorectal cancer population: a cross-sectional study. Annals of Medicine & Surgery, 85(5), 1761-1768. https://doi.org/https://doi.org/10.1097/ms9.0000000000000694

Sarasqueta, C., Perales, A., Escobar, A., Baré, M., Redondo, M., Larrea, N. F. De, Briones, E., & Piera, J. M. (2019). Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer : patients with stage III colon or stage II / III rectal cancer. BMC Cancer, 19, 1-15.

Stamatakis, K., Jime, M., Hidalgo-este, A. M., & Lo, R. (2020). Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer. Frontiers in Pharmacology, 11(April), 1-13. https://doi.org/10.3389/fphar.2020.00533

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660

Wu, X., Lin, H., & Li, S. (2019). Prognoses of different pathological subtypes of colorectal cancer at different stages : A population-based retrospective cohort study. BMC Gastroenterology, 19, 1-8.

Yan, S., Zhan, F., He, Y., Zhu, Y., & Ma, Z. (2025). p53 in colorectal cancer : from a master player to a privileged therapy target. Journal of Translational Medicine. https://doi.org/10.1186/s12967-025-06566-4

Yang, Z., Wang, X., Zhou, H., Jiang, M., Wang, J., & Sui, B. (2024). Molecular Complexity of Colorectal Cancer : Strategies Molecular Complexity of Colorectal Cancer : Pathways , Biomarkers , and Therapeutic Strategies. Cancer Management and Research, 16, 1389-1402. https://doi.org/10.2147/CMAR.S481656

Yoo, H. J., Kim, T. J., Kim, D. J., & Kim, W. (2020). Role of COX2 as a Biomarker for Estimating Survival of Patients With Clinical Stage I Gastric Cancer. Anticancer Research, 40, 341-347. https://doi.org/10.21873/anticanres.13958

Yu, X., Wu, H., Wu, B., Zhi, S., Lan, Y., Chen, W., & Liu, J. (2025). Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer. World Journal of Gastrointestinal Oncology, 17(7), 1-18. https://doi.org/10.4251/wjgo.v17.i7.107681

Zhang, Q., Dong, G., Wang, F., & Ding, W. (2020). Correlation between the changes of serum COX 2 , APE1 , VEGF , TGF - β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. Journal of Cancer Research and Therapeutics, 16(2), 335-342. https://doi.org/10.4103/jcrt.JCRT

Zhou, S., Zhao, Z., Wang, Z., Xu, H., Li, Y., Xu, K., & Li, W. (2025). Cancer-associated fibroblasts in carcinogenesis. Journal of Translational Medicine, 23(50), 1-14.

(5), 536-542.

Downloads

Published

2025-12-31

Issue

Vol. 7 No. 3 (2025): CONTAGION

Section

Articles

License

COPYRIGHT

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges as well as earlier and greater citation of published work (see The Effect of Open Access).
LICENSE

CONTAGION (Scientific Periodical Journal of Public Health and Coastal Health) is published under the terms of the Creative Commons Attribution-ShareAlike 4.0 International License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.